Device Firms Would Have To Report Value Of Device Samples For Patient Use Under STAR Act
An amendment to the Physician Payment Sunshine Act approved by a House Committee on April 9 would require device manufacturers to report the value of any samples given to physicians, a requirement that could include some free samples a doctor uses when educating his patients on device use.
You may also be interested in...
CMS has finalized several sunshine rule provisions: the definition of “applicable manufacturer” has been narrowed; many payments to speakers at continuing medical education programs and events need not be reported; and the agency will allow manufacturers to supply contextual information on the public database.
The US Senate overwhelmingly approved a bill on 16 January to implement the US-Mexico-Canada agreement, which includes a new chapter on the handling of medical devices supported by the medtech industry.